A groundbreaking trial across 11 countries reveals a triple-action cancer jab can completely eradicate tumours in patients with advanced, treatment-resistant cancers.

Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy

A promising triple-action cancer jab being trialled at the Royal Marsden has shown encouraging results for some patients with head and neck cancer, with tumours disappearing…

The results of the trial will be presented during the American Society of Clinical Oncology annual meeting in Chicago

The effectiveness of amivantamab is being evaluated in around 60 clinical trials worldwide.

LONDON, May 31 — Doctors have reported striking results from an international trial of a triple action cancer jab that eliminated tumours in some patients.According to The...

A triple-action cancer jab blocked a crucial protein that helps cancers grow and stopped a second pathway that tumour cells use to evade treatment, while also activating the…

An experimental cancer injection has shown promising results in a clinical trial, shrinking or eliminating tumors in some patients with advanced head and...

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

A new experimental cancer treatment is generating significant excitement among oncologists after clinical trial results showed it can dramatically shrink tumors and, in some…

I medici li hanno definiti risultati "senza precedenti": una sperimentazione clinica dimostra come un vaccino antitumorale a tripla azione possa eliminare interi tumori nei...

A groundbreaking trial across 11 countries reveals a triple-action cancer jab can completely eradicate tumours in patients with advanced, treatment-resistant cancers.

An experimental pill can shrink tumours by nearly a third in six of the world's most difficult to treat cancers, early trial results have found.